Treatment for COVID-19 in High-Risk Adult Outpatients
Public ClinicalTrials.gov record NCT04354428. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults: An Adaptive Randomized Platform Trial
Study identification
- NCT ID
- NCT04354428
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- University of Washington
- Other
- Enrollment
- 289 participants
Conditions and interventions
Conditions
Interventions
- Ascorbic Acid Drug
- Hydroxychloroquine Sulfate Drug
- Azithromycin Drug
- Folic Acid Drug
- Lopinavir 200 MG / Ritonavir 50 MG [Kaletra] Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 15, 2020
- Primary completion
- Nov 2, 2020
- Completion
- Nov 29, 2020
- Last update posted
- Aug 7, 2022
2020
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ruth M. Rothstein CORE Center - Cook County Health | Chicago | Illinois | 60612 | — |
| Tulane University | New Orleans | Louisiana | 70118 | — |
| Boston University | Boston | Massachusetts | 02215 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| University of Washington Coordinating Center | Seattle | Washington | 98104 | — |
| UW Virology Research Clinic | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04354428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04354428 live on ClinicalTrials.gov.